Tg Therapeutics (TGTX) Other financing activities (2012 - 2026)
Tg Therapeutics (TGTX) recorded quarterly Other financing activities of $2.6 million in Q1 2026, up 8280.65% quarter-over-quarter from $31000.0 in Q4 2024.
Tg Therapeutics (TGTX) Other financing activities (2012 - 2026) Analysis & Trends
Tg Therapeutics' Other financing activities history runs 9 years deep, the most recent figure standing at $2.6 million for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (up 195.73% YoY), while the FY2024 annual figure was $889000.0, up 611.2% from the prior year.
- Other financing activities was $2.6 million for Q1 2026 at Tg Therapeutics, up from $31000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $2.6 million in Q1 2026 to a low of $31000.0 in Q4 2024.
- Historically, Other financing activities has averaged $903000.0 across 3 years, with a median of $491500.0 in 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.60 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2024 | 31,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 858,000.00 |
| Sep 30, 2024 | 858,000.00 |
| Mar 31, 2023 | 125,000.00 |
| Mar 31, 2023 | 125,000.00 |
| Dec 31, 2019 | 315,000.00 |
| Dec 31, 2019 | 315,000.00 |
| Jun 30, 2019 | -58,000.00 |
| Jun 30, 2019 | -58,000.00 |
| Mar 31, 2019 | 538,000.00 |
| Mar 31, 2019 | 538,000.00 |
| Dec 31, 2016 | 3,016.00 |
| Dec 31, 2016 | 3,016.00 |
| Sep 30, 2016 | 5,995.00 |
| Sep 30, 2016 | 5,995.00 |
| Jun 30, 2016 | -4,011.00 |
| Jun 30, 2016 | -4,011.00 |